{"id":"W2570785609","doi":"10.1016/j.jtho.2016.11.006","title":"PL03.03: Randomized Phase III Study of Osimertinib vs Platinum-Pemetrexed for EGFR T790M-Positive Advanced NSCLC (AURA3)","year":2017,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Osimertinib; Pemetrexed; Medicine; T790M; Internal medicine; Oncology; Carboplatin; Erlotinib; Chemotherapy; Cisplatin; Epidermal growth factor receptor; Gefitinib; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001689625,0.002206392,0.002985029,0.0004838571,0.0005496096,0.002252545,0.001693962,0.001789184,0.0108499],"category_scores_gemma":[0.001319484,0.000985234,0.00253908,0.000628864,0.001812511,0.001780374,0.0005581627,0.005683395,0.002737693],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00159755,"about_ca_system_score_gemma":0.002137388,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002772506,"about_ca_topic_score_gemma":0.006038838,"domain_scores_codex":[0.9995467,0.0001816138,0.00002608338,0.00008517526,0.00003100836,0.0001293941],"domain_scores_gemma":[0.9992995,0.0001438475,0.0001381124,0.0000649636,0.00003094566,0.0003225907],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9667528,0.005267399,0.0006067638,0.0003513281,0.0008926002,0.00004409117,0.00005050196,0.0007427953,0.002779607,0.0002251419,0.002277981,0.02000899],"study_design_scores_gemma":[0.9606006,0.03594612,0.001101759,0.00001698874,0.0003342151,0.00003611742,0.00002768868,0.0006243091,0.0003575865,0.0002840755,0.0006563668,0.00001413827],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9796948,0.003578649,0.001280663,0.001739949,0.001127902,0.003162285,0.003373599,0.0005089616,0.005533196],"genre_scores_gemma":[0.9806657,0.002065299,0.001710958,0.002293771,0.0005091492,0.003097001,0.002676557,0.0001188561,0.006862596],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0108499,"threshold_uncertainty_score":0.03629649,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02999998900557982,"score_gpt":0.4933886263280734,"score_spread":0.4633886373224936,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}